Brief: CellSeed starts clinical trial regarding esophageal regenerative cell sheet

CellSeed

10/08/2016 08:25

Aug 10 (Reuters) - CellSeed  7776.T : 
     
    * Says it has signed contract and commenced clinical trial 
regarding esophageal regenerative cell sheet products with code 
CLS2702C/D 
    * Says this product aims to shorten wound healing period 
after Endoscopic Submucosal Dissection(ESD) 
     
     
    Source text in Japanese:http://985.so/ASpS 
    Further company coverage: 7776.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: Doris.li@thomsonreuters.com@reuters.net))